Neuronetics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neuronetics and other ETFs, options, and stocks.

About STIM

Neuronetics, Inc. is a commercial stage medical technology company, which focuses on designing, developing and marketing products that improve the quality of life for patients who suffer from neurohealth disorders. It operates through United States and International geographical segments. 

CEO
Daniel L. Reuvers
CEODaniel L. Reuvers
Employees
658
Employees658
Headquarters
Malvern, Pennsylvania
HeadquartersMalvern, Pennsylvania
Founded
1998
Founded1998
Employees
658
Employees658

STIM Key Statistics

Market cap
329.89M
Market cap329.89M
Price-Earnings ratio
-7.29
Price-Earnings ratio-7.29
Dividend yield
Dividend yield
Average volume
4.56M
Average volume4.56M
High today
$3.20
High today$3.20
Low today
$3.08
Low today$3.08
Open price
$3.15
Open price$3.15
Volume
3.93K
Volume3.93K
52 Week high
$3.98
52 Week high$3.98
52 Week low
$0.80
52 Week low$0.80

Stock Snapshot

With a market cap of 329.89M, Neuronetics(STIM) trades at $3.19. The stock has a price-to-earnings ratio of -7.29.

During the trading session on 2026-08-13, Neuronetics(STIM) shares reached a daily high of $3.20 and a low of $3.08. At a current price of $3.19, the stock is +3.6% higher than the low and still -0.3% under the high.

Trading volume for Neuronetics(STIM) stock has reached 3.93K, versus its average volume of 4.56M.

Over the past 52 weeks, Neuronetics(STIM) stock has traded between a high of $3.98 and a low of $0.80.

Over the past 52 weeks, Neuronetics(STIM) stock has traded between a high of $3.98 and a low of $0.80.

STIM News

Investing.com 2d
Neuronetics stock price target raised to $6 by BTIG on profitability - Investing.com

...

Neuronetics stock price target raised to $6 by BTIG on profitability - Investing.com
Nasdaq 2d
Neuronetics Q2 Earnings Call Highlights

Neuronetics (NASDAQ:STIM) reported second-quarter 2026 revenue growth, a sharply narrower net loss and positive adjusted EBITDA as its Greenbrook clinic busines...

Neuronetics Q2 Earnings Call Highlights
TipRanks 2d
Neuronetics reports Q2 EPS (5c), consensus (12c)

Reports Q2 revenue $41.57M, consensus $40.17M. “This was a quarter of real operational progress, and meaningful steps toward our goal of sustained profitability...

People also own

Based on the portfolios of people who own STIM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.